Gabrielle Gershon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gabrielle Gershon has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Marly van Assen
Department of Radiology and Imaging Sciences, Emory University, Atlanta, USA
3 shared publications - Carlo Nicola De Cecco
Emory University
2 shared publications - Jaret Barr
Department of Radiology and Imaging Sciences, Emory University, 101 Woodruff Cir, Ste 308A, Atlanta, GA 30322
2 shared publications - Laurence S. Sperling
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
2 shared publications - Aawez Mansuri
Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, USA
1 shared publication - Aisha Urooj Khan
Department of Radiology, Mayo Clinic , Phoenix, AZ
1 shared publication
Latest Publications
- 1 August 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (4)
Heart Failure Outcome Prediction Using Artificial Intelligence–enabled Coronary Artery Calcium CT Chamber Volumetry Compared to American Heart Association PREVENT and the Agatston Score for Heart Failure Risk Stratification
Coronary artery calcium (CAC) CT–derived cardiac chamber volumes improved heart failure risk predictions over the PREVENT-HF clinical risk and CAC scores, enabling reliable chamber dilatation assessment in asymptomatic individuals.
- 1 August 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Cardiothoracic Imaging
- Vol. 8 (4)
Heart Failure Outcome Prediction Using Artificial Intelligence–enabled Coronary Artery Calcium CT Chamber Volumetry Compared to American Heart Association PREVENT and the Agatston Score for Heart Failure Risk Stratification
Coronary artery calcium (CAC) CT–derived cardiac chamber volumes improved heart failure risk predictions over the PREVENT-HF clinical risk and CAC scores, enabling reliable chamber dilatation assessment in asymptomatic individuals.
- Top Cited PapersOpen Access
- 9 March 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (18) , 2206-2220
Artificial intelligence–based quantification of breast arterial calcifications to predict cardiovascular morbidity and mortality
Background and Aims: Women are underdiagnosed and undertreated for cardiovascular disease (CVD). Automatic quantification of breast arterial calcification (BAC) on screening mammography can identify women at risk for CVD. This study aimed to determine whether artificial intelligence–based automatic quantification of BAC from screening mammograms predicts CVD and mortality beyond PREVENT scores in a large, racially diverse, multi-institutional population. Methods: This retrospective cohort study included 123 762 women from two healthcare systems who had screening mammograms. Breast arterial calcification was quantified using a transformer-based neural network for segmentation. Breast arterial calcification severity was categorized as zero (0 mm2), mild (>0–10 mm2), moderate (>10–25 mm2), and severe (>25 mm2). Kaplan–Meier analysis, Cox proportional hazards, and Fine–Gray competing event models were used to examine the association between BAC and major adverse cardiovascular events (MACE). Results: Breast arterial calcification was detected in 16.1% (internal cohort) and 20.6% (external cohort) of women and provided significant prognostic value incremental to the PREVENT score. In PREVENT adjusted models, a clear dose–response was observed. Compared with zero BAC, mild [internal: hazard ratio (HR) 1.32, 95% confidence interval (CI) 1.10–1.59; external: HR 1.28, 95% CI 1.17–1.39], moderate (internal: HR 1.75, 95% CI 1.23–2.50; external: HR 1.79, 95% CI 1.55–2.06), and severe BAC (internal: HR 3.29, 95% CI 2.15–5.05; external: HR 2.80, 95% CI 2.36–3.32) were all prognostic for any MACE. Each 1 mm2 increase in BAC conferred an additional 2%–3% risk for MACE (P < .001). Conclusions: Automatically quantified BAC is an independent predictor of MACE and mortality, adding prognostic value to the PREVENT score. This approach may provide an opportunistic cardiovascular risk assessment during routine mammography screening without additional radiation exposure to guide earlier and more effective preventive care for women.
- 9 March 2026
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 47 (18) , 2206-2220
Top Cited PapersOpen AccessArtificial intelligence–based quantification of breast arterial calcifications to predict cardiovascular morbidity and mortality
Background and Aims: Women are underdiagnosed and undertreated for cardiovascular disease (CVD). Automatic quantification of breast arterial calcification (BAC) on screening mammography can identify women at risk for CVD. This study aimed to determine whether artificial intelligence–based automatic quantification of BAC from screening mammograms predicts CVD and mortality beyond PREVENT scores in a large, racially diverse, multi-institutional population. Methods: This retrospective cohort study included 123 762 women from two healthcare systems who had screening mammograms. Breast arterial calcification was quantified using a transformer-based neural network for segmentation. Breast arterial calcification severity was categorized as zero (0 mm2), mild (>0–10 mm2), moderate (>10–25 mm2), and severe (>25 mm2). Kaplan–Meier analysis, Cox proportional hazards, and Fine–Gray competing event models were used to examine the association between BAC and major adverse cardiovascular events (MACE). Results: Breast arterial calcification was detected in 16.1% (internal cohort) and 20.6% (external cohort) of women and provided significant prognostic value incremental to the PREVENT score. In PREVENT adjusted models, a clear dose–response was observed. Compared with zero BAC, mild [internal: hazard ratio (HR) 1.32, 95% confidence interval (CI) 1.10–1.59; external: HR 1.28, 95% CI 1.17–1.39], moderate (internal: HR 1.75, 95% CI 1.23–2.50; external: HR 1.79, 95% CI 1.55–2.06), and severe BAC (internal: HR 3.29, 95% CI 2.15–5.05; external: HR 2.80, 95% CI 2.36–3.32) were all prognostic for any MACE. Each 1 mm2 increase in BAC conferred an additional 2%–3% risk for MACE (P < .001). Conclusions: Automatically quantified BAC is an independent predictor of MACE and mortality, adding prognostic value to the PREVENT score. This approach may provide an opportunistic cardiovascular risk assessment during routine mammography screening without additional radiation exposure to guide earlier and more effective preventive care for women.
- 2 January 2026
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 20 (1) , 63-69
Distribution of coronary artery calcium volume and density by age, sex, and race using AI-based quantification algorithm
- 2 January 2026
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 20 (1) , 63-69
Distribution of coronary artery calcium volume and density by age, sex, and race using AI-based quantification algorithm